New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: AuRico Gold Inc (NYSE:AUQ), DURECT Corporation (NASDAQ:DRRX), Inovio Pharmaceuticals Inc (NYSEMKT:INO), LDK Solar Co., Ltd (ADR) (NYSE:LDK)
AuRico Gold Inc (NYSE:AUQ) showed a volume of 2.47 million shares by the end of last trade whereas the average volume of the stock remained 2.37million shares. The stock opened the session at $4.28 but then moved to $4.47. At that price, the stock showed a positive performance of 3.00%. AuRico Gold Inc. is a Canada-based gold producer with mines and projects in North America. The Company and its subsidiaries are engaged in the mining, development, exploration, and acquisition of resource properties. Its core operations include the Young-Davidson gold mine in northern Ontario and the El Chanate mine in Sonora State, Mexico. Its project pipeline also includes advanced development opportunities in Mexico and British Columbia.
Will AUQ Continue To Move Higher? Find Out Here
DURECT Corporation (NASDAQ:DRRX) opened the session at $2.07 and closed the session at $2.04. The stock showed a negative performance of -0.97% in previous trading session. Traded with volume of 2.44 million shares in the prior session and the average volume of the stock remained 814,289.00 shares. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA),
Has DRRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Inovio Pharmaceuticals Inc (NYSEMKT:INO) opened the session at $2.50 and closed the session at $2.44. The stock showed a negative performance of -0.41% in previous trading session. Traded with volume of 2.42 million shares in the prior session and the average volume of the stock remained 5.50 million shares. The beta of the stock remained 3.26. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
LDK Solar Co., Ltd (ADR) (NYSE:LDK) the stock decreased -4.51% and finished the session at $1.27. Traded with volume of 2.40 million shares in the prior session and the average volume of the stock remained 1.16 million shares. The beta of the stock remained 3.06. LDK Solar Co., Ltd. is a vertically integrated manufacturer of Photovoltaic (PV) products. The Company’s products include Polysilicon, Solar Wafers, Solar Cells, Solar Modules and Solar Farm Projects. It operates in two segments: Polysilicon and Other PV products. Polysilicon segment involves the production and sales of polysilicon.
Will LDK Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)